Security key
G6724L116
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)
CUSIP: G6724L116
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 665,294
- Total 13F value
- $1,147,535
- Share change
- -1,906,444
- SEC-reported price per share
- $2.07
- Number of holders
- 10
- Value change
- -$2,989,322
- Number of buys
- 4
- Number of sells
- 3
- Shares outstanding
- 52,174,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
10
Top holders
10
OKYO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
OKYO Pharma Ltd SEC filings
OKYO Pharma Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6724L116
Recent filing periods:
Ownership snapshot
Top reported holders of OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jorey Chernett
Disclosed value leader
Jorey Chernett
Comparable rows
10/10
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 9.5%
13D/G row: Jorey Chernett
Showing 1-6 of 10 holder rows.
Quick read
Jorey Chernett leads the comparable SEC ownership view at 9.5%.
10 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jorey Chernett's linked filing trail.
Comparable ownership
Top 5
Jorey Chernett
9.5%
Laura Natalia Monica Fonda
5%
Dauntless Investment Group, LLC
1.2%
NORTHERN TRUST CORP
0.11%
RENAISSANCE TECHNOLOGIES LLC
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
Chernett Jorey
|
9.5%
|
$11,824,823
3,802,194 shares
|
+$2,541,903 | 31 Dec 2025 |
| Laura Natalia Monica Fonda |
13D/G
|
5%
|
$3,856,902
1,928,451 shares
|
$0 | 22 Jul 2025 |
| Dauntless Investment Group, LLC |
13F
13D/G
Company
|
1.2%
from 13D/G
|
$4,844,096
2,422,048 shares
|
— | 30 Sep 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.11%
|
$114,316
57,158 shares
|
— | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.08%
|
$82,400
41,200 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.03%
|
$30,710
15,355 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
665,294
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
8
Q4 2025 holders
10
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend